Who we are
The National Gynae-Oncology Registry (NGOR) is a clinical quality registry that monitors the quality of care provided to Australian women diagnosed with gynaecological cancers (cancers of the female reproductive system). The registry is managed by a team in the Cancer Research Program, part of the School of Public Health and Preventive Medicine at Monash University.
The NGOR is designed to measure and monitor patterns of care following diagnosis of cancers of the female reproductive system. The aim of this registry is to identify variation in the treatments and outcomes of patients with newly diagnosed gynaecological cancers, with a view to improving patient outcomes and quality of care.
The registry is currently recruiting patients with newly-diagnosed ovarian, tubal, peritoneal and endometrial cancers whose care was managed by a participating gynaecological oncologist at an approved hospital. The NGOR is in the process of expanding to include cervical and vulvo-vaginal cancers. We aim to include all gynaecological cancers in the future. To view a list of participating hospitals and clinicians, refer to the Participating Health Services and Hospitals page.
More than 1500 women with newly-diagnosed ovarian, tubal, peritoneal and endometrial cancers have been recruited to date
37 Gynaecological Cancer Specialists (Gynaecological Oncologists and Medical Oncologists) are participating
20 public and private hospitals across Victoria, Tasmania, New South Wales, South Australia and Western Australia are actively participating in NGOR, with applications for 16 more sites in progress across these five states and Queensland.